Dr. Kennedy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 617-732-7420
Summary
- Dr. John Kennedy is a pulmonologist in Boston, MA and is affiliated with multiple hospitals in the area, including Brigham and Women's Hospital, Strong Memorial Hospital of the University of Rochester, and Boston Children's Hospital. He received his medical degree from University of New Mexico School of Medicine and has been in practice 7 years. He specializes in critical care medicine and pleural disease and is experienced in cystic fibrosis, pulmonology, critical care medicine, pulmonary transplantation, and cystic fibrosis exacerbation.
Education & Training
- Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2014 - 2018
- University of RochesterResidency, Internal Medicine/Pediatrics, 2010 - 2014
- University of New Mexico School of MedicineClass of 2010
- Trinity collegeM.Sc., Molecular Medicine, 2001 - 2002
Certifications & Licensure
- NY State Medical License 2013 - 2026
- MA State Medical License 2014 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Internal Medicine Pediatrics Quality Award The University of Rochester, 2010
Publications & Presentations
PubMed
- 46 citationsThe effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosisKevin J. Scully, Peter Marchetti, Gregory S. Sawicki, Ahmet Uluer, Manuela Cernadas
Journal of Cystic Fibrosis. 2021-09-13 - 61 citationsCellular and molecular mechanisms of heat stress-induced up-regulation of occludin protein expression: regulatory role of heat shock factor-1.Karol Dokladny, Dongmei Ye, John C. Kennedy, Pope L. Moseley, Thomas Y. Ma
The American Journal of Pathology. 2008-03-01 - 3 citationsA homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findings.Qifei Li, Michal Dibus, Alicia Casey, Christina S.K. Yee, Sara O. Vargas
Plos Genetics. 2021-07-07
Grant Support
- Program for Adult Care ExcellenceCystic Fibrosis Foundation2018–2020
Professional Memberships
- Member
- Member
- Member
- International Society for Stem Cell ResearchFormer member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: